These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 15776824

  • 1. [Treatment of renal tuberculosis].
    Kamyshan IS, Mams AN.
    Urologiia; 2005; (1):9-12. PubMed ID: 15776824
    [Abstract] [Full Text] [Related]

  • 2. [Comparative evaluation of therapeutic effects of 3 and 4 antitubercular agents at the initial stage of the treatment of renal tuberculosis].
    Kamyshan IS, Pavlova LP, Mams AN, Saĭdakova NA, Stepanov PI.
    Probl Tuberk Bolezn Legk; 2004; (10):15-9. PubMed ID: 15568312
    [Abstract] [Full Text] [Related]

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 4. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL, Xie YG, Tan WG, Chu NH, Li L, You YH, Yang YZ, Wang XM, Yan XL, Miao ZP, Duanmu HJ.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [Abstract] [Full Text] [Related]

  • 5. [Complications of polychemotherapy for renal tuberculosis].
    Kul'chavenia EV, Kuznetsov PV.
    Probl Tuberk; 1998 Feb; (1):28-30. PubMed ID: 9553430
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M, Nakajima Y.
    Kekkaku; 2006 Jan; 81(1):35-50. PubMed ID: 16479999
    [Abstract] [Full Text] [Related]

  • 7. [Effects of two treatment regimens for drug-resistant tuberculosis in tuberculosis control project areas: a comparative study].
    Li L, Zheng SH, Chu NH, Xie YG, Yang YZ, Li Q, Wang XM, Yan XL, Tan WG, Miao ZP, Duanmu HJ.
    Zhonghua Yi Xue Za Zhi; 2008 Dec 30; 88(48):3387-91. PubMed ID: 19159566
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between the results of therapy with antitubercular drugs and the extent and the form of renal tuberculous lesions].
    Brauner G.
    Pol Przegl Chir; 1969 Dec 30; 41(5):700-5. PubMed ID: 5815199
    [No Abstract] [Full Text] [Related]

  • 9. [Comparative evaluation of 113 cases with severe and mild forms of extrapulmonary tuberculosis].
    Turunç T, Habeşoğlu MA, Demiroğlu YZ, Karataşli M, Sen N, Ermiş H, Alişkan H, Colakoğlu S, Arslan H.
    Mikrobiyol Bul; 2008 Jul 30; 42(3):399-406. PubMed ID: 18822882
    [Abstract] [Full Text] [Related]

  • 10. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
    Yoshiyama T, Ogata H, Ito K, Aono A, Wada M.
    Kekkaku; 2007 Feb 30; 82(2):95-101. PubMed ID: 17373318
    [Abstract] [Full Text] [Related]

  • 11. Renal tuberculosis in adult polycystic kidney disease: report of 2 cases and review of the literature.
    Simões do Espírito Santo K, Teixeira Vde P, Costa Hde O, Franco M.
    Int J Surg Pathol; 2007 Apr 30; 15(2):196-8. PubMed ID: 17478782
    [Abstract] [Full Text] [Related]

  • 12. [Individual approaches to complex treatment of disseminated tuberculous processes in adolescents].
    Gergert VIa, Rusakova LI.
    Probl Tuberk Bolezn Legk; 2006 Apr 30; (8):33-7. PubMed ID: 17002056
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN, Hong SB, Oh YM, Kim MN, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS.
    J Antimicrob Chemother; 2006 Sep 30; 58(3):701-4. PubMed ID: 16857689
    [Abstract] [Full Text] [Related]

  • 14. [Radical-preventive surgery in cavernous tuberculosis of the kidneys].
    Shapkin AG.
    Vestn Khir Im I I Grek; 1986 Dec 30; 137(12):50-6. PubMed ID: 3824804
    [Abstract] [Full Text] [Related]

  • 15. A 6-month regimen for EPTB with intermittent treatment in the continuation phase: a study of 679 cases.
    Caminero JA, Fuentes ZM, Martín TY, España M, Istúriz GJ, Millán EA, Alfonzo E, Castillo OY, Cabrera P, Guilarte A.
    Int J Tuberc Lung Dis; 2005 Aug 30; 9(8):890-5. PubMed ID: 16104636
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 30; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Principles of drug therapy in urogenital tuberculosis].
    Jungbluth H.
    Urologe A; 1984 Jul 30; 23(4):189-93. PubMed ID: 6540914
    [Abstract] [Full Text] [Related]

  • 19. [Clinical and bacteriological manifestations of nonspecific infection of the urinary tract and dysbacteriosis in patients with tuberculosis of the kidneys].
    Kaliuk AN, Danilova NK, Strel'nikova VA.
    Ter Arkh; 1987 Jul 30; 59(12):6-9. PubMed ID: 3128884
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R, Verma SK, Sahai S, Kumar S, Jain A.
    Indian J Chest Dis Allied Sci; 2006 Jul 30; 48(3):183-6. PubMed ID: 18610675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.